Related Experiment Video
Updated: Apr 7, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Applications of the Keap1-Nrf2 system for gene and cell therapy
Katja M Kanninen1, Yuriy Pomeshchik1, Hanna Leinonen2
1Department of Neurobiology, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Finland.
Abstract:
Oxidative stress has been implicated to play a role in a number of acute and chronic diseases including acute injuries of the central nervous system, neurodegenerative and cardiovascular diseases, and cancer. The redox-activated transcription factor Nrf2 has been shown to protect many different cell types and organs from a variety of toxic insults, whereas in many cancers, unchecked Nrf2 activity increases the expression of cytoprotective genes and, consequently, provides growth advantage to cancerous cells. Herein, we discuss current preclinical gene therapy approaches to either increase or decrease Nrf2 activity with a special reference to neurological diseases and cancer. In addition, we discuss the role of Nrf2 in stem cell therapy for neurological disorders.
Insights
Oxidative stress contributes to various diseases. Gene therapy targeting the Nrf2 pathway offers potential treatments for neurological disorders and cancer by modulating its activity.
Area of Science:
- Biochemistry and Molecular Biology
- Neuroscience
- Oncology
Background:
- Oxidative stress is implicated in acute and chronic diseases, including central nervous system injuries, neurodegenerative disorders, cardiovascular diseases, and cancer.
- The transcription factor Nrf2 (Nuclear factor erythroid 2-related factor 2) is a key regulator of cellular defense against oxidative stress.
- While Nrf2 activation provides cytoprotection, its dysregulation in cancer promotes tumor growth by upregulating protective genes.
Purpose of the Study:
- To review preclinical gene therapy strategies aimed at modulating Nrf2 activity.
- To highlight the therapeutic potential of targeting Nrf2 in neurological diseases and cancer.
- To discuss the role of Nrf2 in stem cell therapy for neurological disorders.
Main Methods:
- Review of current preclinical research on gene therapy approaches for Nrf2 modulation.
- Analysis of studies investigating Nrf2's role in cancer cell proliferation and survival.
- Examination of Nrf2's involvement in stem cell-based therapies for neurological conditions.
Main Results:
- Preclinical gene therapy approaches are being developed to either enhance or suppress Nrf2 activity.
- Targeting Nrf2 holds promise for treating both neurological diseases and various cancers.
- Nrf2 plays a significant role in the efficacy of stem cell therapies for neurological disorders.
Conclusions:
- Modulating Nrf2 activity through gene therapy represents a promising therapeutic avenue for oxidative stress-related diseases.
- Further research into Nrf2-targeted therapies is warranted for neurological conditions and cancer treatment.
- Understanding Nrf2's function is crucial for advancing stem cell therapy in neurodegenerative disorders.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Gene Therapy
Mitogens and the Cell Cycle

